Literature DB >> 3280487

Diuretics and their side effects. Dilemma in the treatment of hypertension.

M H Weinberger1.   

Abstract

Diuretics have traditionally been the keystone of antihypertensive therapy. A variety of clinical trials, designed to examine the benefit of blood pressure reduction in decreasing morbidity and mortality from hypertension-related cardiovascular disease, have surprisingly failed to show a decrease in coronary artery disease death rate, although other forms of vascular disease were impressively reduced. These trials have consistently used diuretics as the initial therapeutic choice. Such observations have stimulated a reevaluation of the "stepped-care" approach and a critical appraisal of diuretic effects. This review examines the efficacy of diuretics in reducing blood pressure and attempts to identify individuals most likely to respond to these agents. The side effects of diuretic therapy are reviewed in hemodynamic, cardiac, metabolic, and symptomatic terms, but because some of these aspects of diuretic or antihypertensive therapy are detailed elsewhere in this monograph, the present discussion focuses on cardiac, metabolic, hemodynamic, and symptomatic effects. Finally, alternative therapeutic options and guidelines for therapy are outlined.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3280487     DOI: 10.1161/01.hyp.11.3_pt_2.ii16

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  10 in total

Review 1.  Is salt restriction relevant and feasible as adjunctive treatment of hypertension?

Authors:  M H Weinberger
Journal:  Drugs       Date:  1990-06       Impact factor: 9.546

Review 2.  Postural blood pressure changes and orthostatic hypotension in the elderly patient: impact of antihypertensive medications.

Authors:  Ihab Hajjar
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

3.  Meta-analysis: impact of drug class on adherence to antihypertensives.

Authors:  Ian M Kronish; Mark Woodward; Ziad Sergie; Gbenga Ogedegbe; Louise Falzon; Devin M Mann
Journal:  Circulation       Date:  2011-04-04       Impact factor: 29.690

Review 4.  Racial differences in antihypertensive therapy: evidence and implications.

Authors:  M H Weinberger
Journal:  Cardiovasc Drugs Ther       Date:  1990-03       Impact factor: 3.727

Review 5.  Trials in isolated systolic hypertension: an update.

Authors:  Bernard Waeber
Journal:  Curr Hypertens Rep       Date:  2003-08       Impact factor: 5.369

Review 6.  Trials in isolated systolic hypertension: an update.

Authors:  Bernard Waeber
Journal:  Curr Cardiol Rep       Date:  2003-11       Impact factor: 2.931

Review 7.  Benefits and risks of torasemide in congestive heart failure and essential hypertension.

Authors:  D C Brater
Journal:  Drug Saf       Date:  1996-02       Impact factor: 5.606

Review 8.  Primary prevention potential of the calcium antagonists. Effects on blood pressure and lipid pattern.

Authors:  K Midtbø
Journal:  Drugs       Date:  1992       Impact factor: 9.546

Review 9.  Pharmacological management of hypertension in paediatric patients. A comprehensive review of the efficacy, safety and dosage guidelines of the available agents.

Authors:  K Miller
Journal:  Drugs       Date:  1994-12       Impact factor: 9.546

10.  A comparison of the effect of lisinopril and hydrochlorothiazide on electrolyte balance in essential hypertension.

Authors:  D B Frewin; R C Bartholomeusz; R D Gaffney; A D Clampett; B E Chatterton
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.